Aurinia Pharmaceuticals Current Cash

Aurinia Pharmaceuticals (AUPH) currently reports a current cash of $41M as of March 2026. That compares with $66M in the prior-year period — down 38.3% year over year. Use the charts on this page to explore Aurinia Pharmaceuticals's current cash history and peer comparisons.

Aurinia Pharmaceuticals's current cash decreased from $66M to $41M — a 38.3% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aurinia Pharmaceuticals reported $41M in current cash as of March 2026. That compares with $66M in the prior-year period — down 38.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $41M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aurinia Pharmaceuticals, and consider following AUPH for alerts when major investors trade the stock.

Aurinia Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $41M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AUPH with unrelated industries.